🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in individuals administering products of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Elimination

Based on the social media company, the platform has removed violative content and prohibited related hashtags and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also found groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.

Within moments of entering one group, a seller posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Pricing

Inside these communities, messages show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a injector should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly significant health risks”.